Page last updated: 2024-08-16

rabeprazole and ritonavir

rabeprazole has been researched along with ritonavir in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Crum, NF; Furtek, KJ; Olson, PE; Wallace, MR	1
Benet, LZ; Faber, KP; Frassetto, LA; Kadiyala, P; Wu, HF; Xu, X; Yago, MR	1

Reviews

1 review(s) available for rabeprazole and ritonavir

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for rabeprazole and ritonavir

Article	Year
Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption. Pharmaceutical research, 2017, Volume: 34, Issue:3 Topics: Absorption, Physiological; Achlorhydria; Administration, Oral; Adult; Atazanavir Sulfate; Betaine; Cross-Over Studies; Drug Interactions; Female; Food-Drug Interactions; HIV Protease Inhibitors; Humans; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Ritonavir; Young Adult	2017

Article

Year

Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption.

Pharmaceutical research, 2017, Volume: 34, Issue:3

Topics: Absorption, Physiological; Achlorhydria; Administration, Oral; Adult; Atazanavir Sulfate; Betaine; Cross-Over Studies; Drug Interactions; Female; Food-Drug Interactions; HIV Protease Inhibitors; Humans; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Ritonavir; Young Adult

2017

Other Studies

2 other study(ies) available for rabeprazole and ritonavir

Article	Year
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Proton pump inhibitor therapy in atazanavir-treated patients: contraindicated? Journal of acquired immune deficiency syndromes (1999), 2006, Volume: 41, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzimidazoles; Contraindications; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Oligopeptides; Omeprazole; Proton Pump Inhibitors; Pyridines; Rabeprazole; Ritonavir	2006

Article

Year

Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.

Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010

Proton pump inhibitor therapy in atazanavir-treated patients: contraindicated?

Journal of acquired immune deficiency syndromes (1999), 2006, Volume: 41, Issue:3

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzimidazoles; Contraindications; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Oligopeptides; Omeprazole; Proton Pump Inhibitors; Pyridines; Rabeprazole; Ritonavir

2006